Trial
NCT02813655
Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE)
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Hospices Civils de Lyon
Collaborators
—
Condition
Post-dural Puncture Headache
Intervention
Tetracosactide (Synacthène®)
Why stopped
Interim analysis and decision of the independent committee, investigators and sponsor (futility) (2023/10/05)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-08